136 related articles for article (PubMed ID: 36538966)
1. Effective role of Curcumin on expression regulation of EZH2 histone methyltransferase as a dynamic epigenetic factor in osteogenic differentiation of human mesenchymal stem cells.
Ghorbaninejad M; Khademi-Shirvan M; Hosseini S; Meyfour A; Shahhoseini M; Baghaban Eslaminejad M
Biochim Biophys Acta Gene Regul Mech; 2023 Mar; 1866(1):194903. PubMed ID: 36538966
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.
Dudakovic A; Camilleri ET; Xu F; Riester SM; McGee-Lawrence ME; Bradley EW; Paradise CR; Lewallen EA; Thaler R; Deyle DR; Larson AN; Lewallen DG; Dietz AB; Stein GS; Montecino MA; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2015 Nov; 290(46):27604-17. PubMed ID: 26424790
[TBL] [Abstract][Full Text] [Related]
3. Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells.
Hemming S; Cakouros D; Vandyke K; Davis MJ; Zannettino AC; Gronthos S
Stem Cells Dev; 2016 Jun; 25(12):909-21. PubMed ID: 27168161
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2.
Dudakovic A; Samsonraj RM; Paradise CR; Galeano-Garces C; Mol MO; Galeano-Garces D; Zan P; Galvan ML; Hevesi M; Pichurin O; Thaler R; Begun DL; Kloen P; Karperien M; Larson AN; Westendorf JJ; Cool SM; van Wijnen AJ
J Biol Chem; 2020 Jun; 295(23):7877-7893. PubMed ID: 32332097
[TBL] [Abstract][Full Text] [Related]
5. Osteogenic Stimulation of Human Adipose-Derived Mesenchymal Stem Cells Using a Fungal Metabolite That Suppresses the Polycomb Group Protein EZH2.
Samsonraj RM; Dudakovic A; Manzar B; Sen B; Dietz AB; Cool SM; Rubin J; van Wijnen AJ
Stem Cells Transl Med; 2018 Feb; 7(2):197-209. PubMed ID: 29280310
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells.
Zhu XX; Yan YW; Chen D; Ai CZ; Lu X; Xu SS; Jiang S; Zhong GS; Chen DB; Jiang YZ
Oncotarget; 2016 Sep; 7(39):63561-63570. PubMed ID: 27566578
[TBL] [Abstract][Full Text] [Related]
7. Enhancer of zeste homolog 2 (
Dudakovic A; Camilleri ET; Paradise CR; Samsonraj RM; Gluscevic M; Paggi CA; Begun DL; Khani F; Pichurin O; Ahmed FS; Elsayed R; Elsalanty M; McGee-Lawrence ME; Karperien M; Riester SM; Thaler R; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2018 Aug; 293(33):12894-12907. PubMed ID: 29899112
[TBL] [Abstract][Full Text] [Related]
8. Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of zeste homolog 2 (Ezh2) accelerate osteoblast differentiation.
Galvan ML; Paradise CR; Kubrova E; Jerez S; Khani F; Thaler R; Dudakovic A; van Wijnen AJ
Bone; 2021 Sep; 150():115993. PubMed ID: 33940225
[TBL] [Abstract][Full Text] [Related]
9. Combination of BMP2 and EZH2 Inhibition to Stimulate Osteogenesis in a 3D Bone Reconstruction Model.
Lui H; Samsonraj RM; Vaquette C; Denbeigh J; Kakar S; Cool SM; Dudakovic A; van Wijnen AJ
Tissue Eng Part A; 2021 Aug; 27(15-16):1084-1098. PubMed ID: 33234056
[TBL] [Abstract][Full Text] [Related]
10. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
[TBL] [Abstract][Full Text] [Related]
11. TiO
Li S; Deng Q; Si Q; Li J; Zeng H; Chen S; Guo T
Biomed Mater; 2023 Aug; 18(5):. PubMed ID: 37437580
[TBL] [Abstract][Full Text] [Related]
12. Silencing of LncRNA-ANCR Promotes the Osteogenesis of Osteoblast Cells in Postmenopausal Osteoporosis via Targeting EZH2 and RUNX2.
Cai N; Li C; Wang F
Yonsei Med J; 2019 Aug; 60(8):751-759. PubMed ID: 31347330
[TBL] [Abstract][Full Text] [Related]
13. The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization.
Dashti P; van de Peppel J; Thaler R; Paradise CR; Stein GS; Montecino MA; van Leeuwen JPTM; van der Eerden BJ; Dudakovic A; van Wijnen AJ
Gene; 2023 Jan; 851():146928. PubMed ID: 36191822
[TBL] [Abstract][Full Text] [Related]
14. Enhancer of Zeste Homolog 2 and Histone Deacetylase 9c Regulate Age-Dependent Mesenchymal Stem Cell Differentiation into Osteoblasts and Adipocytes.
Chen YH; Chung CC; Liu YC; Yeh SP; Hsu JL; Hung MC; Su HL; Li LY
Stem Cells; 2016 Aug; 34(8):2183-93. PubMed ID: 27250566
[TBL] [Abstract][Full Text] [Related]
15. Abnormally elevated EZH2-mediated H3K27me3 enhances osteogenesis in aortic valve interstitial cells by inhibiting SOCS3 expression.
Xie K; Zeng J; Wen L; Peng X; Lin Z; Xian G; Guo Y; Yang X; Li P; Xu D; Zeng Q
Atherosclerosis; 2023 Jan; 364():1-9. PubMed ID: 36455343
[TBL] [Abstract][Full Text] [Related]
16. FGFR2 accommodates osteogenic cell fate determination in human mesenchymal stem cells.
Zhang Y; Ling L; Ajay D/O Ajayakumar A; Eio YM; van Wijnen AJ; Nurcombe V; Cool SM
Gene; 2022 Apr; 818():146199. PubMed ID: 35093449
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer Effects of Curcumin on Myelodysplastic Syndrome through the Inhibition of Enhancer of Zeste Homolog-2 (EZH2).
Ma L; Zhang X; Wang Z; Huang L; Meng F; Hu L; Chen Y; Wei J
Curr Cancer Drug Targets; 2019; 19(9):729-741. PubMed ID: 30747066
[TBL] [Abstract][Full Text] [Related]
18. Decreased bone resorption in Ezh2 myeloid cell conditional knockout mouse model.
Caviness PC; Gai D; Lazarenko OP; Blackburn ML; Zhan F; Chen JR
FASEB J; 2023 Jul; 37(7):e23019. PubMed ID: 37272906
[TBL] [Abstract][Full Text] [Related]
19. Loss of histone methyltransferase Ezh2 stimulates an osteogenic transcriptional program in chondrocytes but does not affect cartilage development.
Camilleri ET; Dudakovic A; Riester SM; Galeano-Garces C; Paradise CR; Bradley EW; McGee-Lawrence ME; Im HJ; Karperien M; Krych AJ; Westendorf JJ; Larson AN; van Wijnen AJ
J Biol Chem; 2018 Dec; 293(49):19001-19011. PubMed ID: 30327434
[No Abstract] [Full Text] [Related]
20. Long non-coding RNA CIR inhibits chondrogenic differentiation of mesenchymal stem cells by epigenetically suppressing ATOH8 via methyltransferase EZH2.
Liu F; Song DY; Huang J; Yang HQ; You D; Ni JD
Mol Med; 2021 Feb; 27(1):12. PubMed ID: 33546582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
